GATEKEEPER is a European Multi Centric Large-Scale Pilot on Smart Living Environments.  The main objective is enabling the creation of a platform that connects healthcare providers, businesses, entrepreneurs, and elderly citizens and the communities they live in, in order to originate an open, trust-based arena for matching ideas, technologies, user needs and processes, aiming to ensure healthier independent lives for the ageing populations.

The scope of GATEKEEPER is the application of advanced Information and Communications Technologies (ICTs) to tackle the challenge of improving the quality of citizens lives while demonstrating its significant gains in health and care delivery across Europe.

Introduction to the pilot

In Greece, the Gatekeeper project will take place from 2019-2023 in Attica and Central Greece and aims to support the active and healthy ageing of citizens through the use of new technologies.



In the Gatekeeper intervention, Big Data Analytics techniques will be exploited to address risk stratification and the early detection of complications of chronic conditions management; data mining for inductive reasoning and exploratory data analysis; Cluster Analysis for identifying high-risk groups among older adults.

Target population

In total, there will be 1,000 volunteer participants with Metabolic Syndrome risk factors, as well as 150 participants with Type 2 Diabetes and comorbidities.

Technologies to be used

  • Advanced sensors (to collect clinical data, such as bio- and physiological signals from smartwatch, CGM, smart scale etc.)
  • Monitoring platform to track patients’ adherence to medical treatment and provide personalised guidance.
  • Artificial Intelligence algorithms.

Expected impact

The expected impact of the Greek pilot site is the lifestyle-related early detection and intervention for chronic conditions impacting the Metabolic Syndrome risk in older adults, as well as functionality and quality of life. It also to achieve the predictive modelling of the glycemic status, the minimisation of hypoglycemic events and eventually the amelioration of glycemic control.